they definitely are nowhere close to having full results (as far as i know they have just recently begun). this is just anecdotal from a discussion with my doctor, who is also fielding patients for the Klimas Rituxim study. I think they have just begun, but when I asked her if it was worth it for me to come back to NYC to take part in study, she said 1) she wouldn't want me to uproot and get placebo; and 2) the results are mixed thus far.
I will give you my doc's name if u like (actually i just noticed she is named in my account info), she is an NYC CFS specialist, if u are a longtime patient I'm sure you could guess. But I would not want to disclose our conversation in a public forum, as it was private and personal.
Is there a clinical trial protocol for this study ?
Also, I presume if it is placebo controlled then it is blinded also. Therefore there would be no results available yet.
The mixed results may have been pertaining to the phase 2 Norway trials ?
It sounds very strange, how can she refer to results if the study is just starting? Firstly, as
@BurnA says the study should be blinded, so there would be no way of knowing anything about results until the blinding is uncoded, which should happen a long way in - preferably years. Fluge and Mella have reported delayed effects in their two latest studies (altogether around 30 patients, if I'm not mistaken), even more of a delay than is usual in other autoimmune disorders. They have reported to me in an e-mail that effects can be expected to kick in from month 5 all the way up to month 11 (that's the
beginning of the effect). A good study should then follow the patients for a long time, in the Norwegian Phase III study it's 2 years.
So I really don't understand what Levine means? Any chance you could ask her some more,
@NicholasNYC?
If she was referring to the Norwegian studies which have been published so far, the results have been that around 2/3 of ME patients have responded to Rituximab and seen a positive effect (differing in size and duration, dramatic for some). I hear anecdotal reports that Kogelnik is getting less great results, but I haven't seen that published or verified.
If anyone sees a clinical protocol (on Clinicaltrials or elsewhere), let us know!